Diese Webseite verwendet Cookies

Diese Seite verwendet Cookies, um Ihnen dieses Angebot leicht zugänglich zu machen, Inhalte zu personalisieren, Ihre Zugriffe auf die Webseite zu analysieren und Ihnen ggf. personalisierte Angebote unterbreiten zu können. Hierzu kann es notwendig sein, dass die Informationen über Ihre Verwendung der Webseite an Partner weitergegeben werden. Diese führen die gesammelten Informationen möglicherweise mit weiteren Daten zusammen, die Sie an anderer Stelle bereitgestellt haben. Eine Weitergabe erfolgt dabei aber nur mit Ihrer Einwilligung und unter Beachtung der datenschutzrechtlichen Vorgaben. Weiterführende Informationen über die hier verwendeten Cookies erfahren Sie in den folgenden Erklärungen zu den jeweiligen Cookies.

Notwendige Cookies helfen dabei, Ihnen die Funktionen der Webseite zugängig zu machen, indem sie Grundfunktionen die zuletzt angesehen Wertpapiere und Ihre Entscheidung für oder gegen die Nutzung der jeweiligen Cookies speichert. Die Webseite wird ohne diese Cookies nicht so funktionieren, wie es geplant ist.

Name Anbieter Zweck Ablauf Typ Verantwortlicher
CookieConsent133 Moneyspecial Um diese Cookiebar auszublenden. 1 Jahr http Infront Financial Technology GmbH
Die Cookie-Erklärung wurde das letzte Mal am 26.06.2020 von Infront Financial Technology GmbH aktualisiert.


New products will accelerate the adoption and scalability of groundbreaking translational and clinical research

LAUSANNE, Switzerland --(BUSINESS WIRE)-- 28.03.2023 --

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced the launch of a full expansion of its product offering to provide a universal, end-to-end spatial biology solution, answering the needs of the scientific community from early discovery to late-stage translational and clinical research. This milestone marks the launch of the enhanced version of the company's revolutionary COMETTM platform and its comprehensive product suite, which includes a wide range of tools and applications across all research and drug development stages.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230328005685/en/

Lunaphore's multiplex immunofluorescence (mIF) solution portfolio now includes the latest version of the hyperplex, high-throughput, fully automated COMETTM instrument, providing unmatched scalability and reproducibility without the need to conjugate primary antibodies. The new SPYRETM Antibody Panel kits, Secondary Antibodies, and an online Panel Builder have been added to the existing offering to help kick-start assay development and enable users with verified biomarkers on COMETTM.

The product suite is further complemented by HORIZONTM, an image analysis software designed and tailored for COMETTM hyperplex images. The software is developed by biologists for biologists to support them in answering fundamental questions about cell profiling and tissue mapping. With Lunaphore's universal portfolio of precision automation solutions, customers can leverage their existing antibody libraries and decades of know-how on Lunaphore's platform to scale assays into endless multiplexing possibilities.

"The spatial biology field is at an inflection point, and Lunaphore is at the forefront of this movement with its radically differentiated technological approach. Since the release of the first COMETTM platform a year ago, we so far observed high customer satisfaction and unmatched traction," said Ata Tuna Ciftlik, CEO at Lunaphore. "We are really excited to launch our comprehensive future-ready solutions. This new COMETTM product suite embeds more than ten years of cutting-edge innovation into powerful tools that accompany our customers, from instant assay creation to streamlined research and analytics. We believe that the COMET TM product suite is a cornerstone solution that will make spatial biology an everyday tool in laboratories around the globe."

"A lot of work in our unit is around preclinical and trial work. We immediately recognized COMETTM as the top platform we were after," said Dr. Andrew Filer, Head of the Birmingham Tissue Analytics Facility at the University of Birmingham. "We wanted a very high plex, fast, and robust instrument. All of the other platforms that were just coming into the market would have one major failure. The reason we liked COMETTM is that it doesn't have any significant weaknesses. It covers all the bases, which is really important to us."

Lunaphore's complete product portfolio will be showcased at the American Association for Cancer Research (AACR) 2023 Annual Meeting through a series of activities and at the Lunaphore booth (#1870). To book a meeting or find out more about Lunaphore's presence at the conference, please visit Lunaphore's website.

To learn more about the new products in Lunaphore's universal, end-to-end solution or start placing requests, please get in touch with the team at: info@lunaphore.com

To learn more about Lunaphore, please visit: https://lunaphore.com/

About Lunaphore

Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore's technology enables the identification of biomarker "signatures" with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit https://lunaphore.com.


COMETTM is the only fully automated, high-throughput, hyperplex platform ensuring scalability and reproducibility without the need to conjugate primary antibodies. COMETTM provides walk-away automation, integrating staining, imaging, and image preprocessing steps to obtain standard hyperplex images. COMETTM generates highly robust and reproducible data with full tissue preservation, allowing researchers to perform downstream modalities such as H&E or transcriptomics using the same slide. Its superior tissue profiling capabilities facilitate the analysis of 40 different spatial markers in each automated run on a tissue slide. In contrast to other spatial biology solutions, COMETTM works with off-the-shelf, label-free primary antibodies, making panel design much more flexible and faster than any other hyperplex solution. COMETTM works with regular glass slides from standard histology workflows; it is validated for human and mouse samples and is compatible with any other animal sample. The platform can be used for a wide range of research applications, allowing for a dramatic improvement in the understanding of disease pathology. Orders of the new COMETTM version can be placed and will be available for shipment in the upcoming months. To learn more about the COMETTM platform, please visit: https://lunaphore.com/products/comet/


HORIZONTM is a tissue analysis software designed to simplify image analysis and evaluation. Tailored to COMETTM hyperplex immunofluorescence images, HORIZONTM extends the COMETTM workflow, providing a seamless integration between both systems, from a hyperplex image to cell phenotyping. HORIZONTM leverages COMETTM-generated images and associated protocol information instantaneously. It can support assay development on COMETTM, as well as image analysis workflows, by rapidly obtaining precise single-cell data for custom downstream analysis. HORIZONTM can perform cell segmentation in a few clicks thanks to a COMETTM-specific, pre-trained algorithm, and the user-friendly and intuitive interface enables hyperplex analysis with no coding experience. With HORIZONTM, it is possible to take full control of hyperplex data, visualizing all image channels with full flexibility and accurately finetuning histograms to see the adjustments applied instantly. The pre-release of HORIZONTM is now available for COMETTM users. To learn more about the HORIZONTM software, please visit: https://lunaphore.com/products/horizon/

About SPYRETM Antibody Panel kits

The four SPYRETM Antibody Panel kits - Immuno-Oncology, Immune, TIL, and T cell Core Panel - lay the foundation of Lunaphore's primary antibody offering and establish the basis for the immuno-oncology reagent portfolio. The assays developed with these kits can be modified or expanded with additional off-the-shelf antibodies from the customer's own library to build custom panels for specific research needs without complexity. The primary antibody offering also includes Panel Builder, an online application providing exclusive access to a library of more than 70 successfully tested off-the-shelf markers and over 300 protocols. It provides an intuitive and convenient way to combine antibodies with SPYRETM Antibody Panels to create panel protocols in silico, allowing ready-to-use COMETTM hyperplex protocols to be automatically generated in a few clicks. Orders of SPYRETM Antibody Panel kits can be placed and will be available for shipment by the summer. To learn more about SPYRETM Antibody Panels, please visit: https://lunaphore.com/spyre-antibody-panels/

For further information contact:
Irene Tamayo
Lunaphore Corporate Communications
Email: communications@lunaphore.com

Business Wire

Zeit Meldung
16:23 BUSINESS WIRE: Europcar entscheidet sich für Bring
16:04 BUSINESS WIRE: FPT und Mila erneuern strategische
15:30 BUSINESS WIRE: Berger Montague (Canada) PC kündigt
15:00 BUSINESS WIRE: Everstream Analytics beruft promine
14:00 BUSINESS WIRE: Die Zukunft des Feedbacks: Leapsome
13:00 BUSINESS WIRE: FIFA Announces AB InBev as Official
12:58 BUSINESS WIRE: Climate Impact X startet CIX Exchan
10:00 BUSINESS WIRE: Stallergenes Greer Foundation Scien
08:50 BUSINESS WIRE: SES Space & Defense Delivers Satell
08:41 BUSINESS WIRE: RevBio erhält Zuschuss in Höhe von
03:32 BUSINESS WIRE: Vizgen richtet offenen Brief an Kun
01:58 BUSINESS WIRE: Brenus Pharma stellt internationale
01:27 BUSINESS WIRE: Wir stellen vor: BEAUTY&YOU 2023: U
01:00 BUSINESS WIRE: Die Veranstaltungsreihen Street Sma
00:39 BUSINESS WIRE: Wipro und Cisco starten Managementl
00:35 BUSINESS WIRE: Küchenchef Marcus Samuelsson invest
00:12 BUSINESS WIRE: Die PPG-Initiative „New Paint for a
07.06. BUSINESS WIRE: Tigo Energy präsentiert den Solar-P
07.06. BUSINESS WIRE: Fluence kündigt große Präsenz und P
07.06. BUSINESS WIRE: Organon und CAF, die Development Ba
07.06. BUSINESS WIRE: IFF Names New President of Nourish
07.06. BUSINESS WIRE: SoftServe übernimmt Hoverstate
07.06. BUSINESS WIRE: Spot by NetApp Survey bestätigt unt
07.06. BUSINESS WIRE: Falcon 40B: Das weltweit beste KI-M
07.06. BUSINESS WIRE: HCLTech führt fortschrittliche Prüf

Mehr Marktdaten und Kurse finden Sie auf www.finanztreff.de

Angebote der
Nutzungshinweise | Datenschutz | Impressum | Datenquellen: boerse-stuttgart.de,